A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome

Human Gene Therapy

Volumn 7, Issue 17, 1996, Pages 2079-2087

  Fisher, Krishna J ^a   Kelley, W Mark ^a   Burda, John F ^a   Wilson, James M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYLYSINE; RECOMBINANT DNA;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DNA VIRUS; EXPRESSION VECTOR; GENE EXPRESSION; GENE REPLICATION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; VIRUS HYBRID;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; DNA VIRUSES; EUKARYOTA;

EID: 0029823797     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.17-2079     Document Type: Article

References (29)

1. BERKNER, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6, 616-629.
2. CARTER, B.J. (1990). The growth cycle of adeno-associated virus. In The Handbook of Parvoviruses. Vol. I., P. Tijsser, ed. (CRC Press, Boca Raton) pp. 155-168.
3. CARTER, B.J., LAUGHLIN, C.A., DE LA MAZA, L.M., and MYERS, M. (1979). Adeno-associated virus autointerference. Virology 92, 449-162.
4. CASTO, B.C., ATCHISON, R.W., and HAMMON, W.M. (1967). Studies on the relationship between adeno-associated virus type I (AAV-I) and adenoviruses. Virology 32, 52-59.
5. DE LA MAZA, L.M., and CARTER, B.J. (1980). Heavy and light particles of adeno-associated virus. J. Virol. 33, 1129-1137.
6. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
7. FISHER, K.J., and WILSON, J.M. (1994). Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochem. J. 299, 49-58.
8. FISHER, K.J., GAO, G.-P., WEITZMAN, M.D., DEMATTEO, R., BURDA, J.F., and WILSON, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
9. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
10. KOTIN, R.M. (1994). Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5, 793-801.
11. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87, 2211-2215.
12. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
13. LAFACE, D., HERMONAT, P., WAKELAND, E., and PECK, A. (1988). Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162, 483-490.
14. LAUGHLIN, C.A., TRATSCHIN, J.-D., COON, H., and CARTER, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73.
15. MILLER, A.D. (1992). Retrovirus vectors. Curr. Topics Microbiol. Immunol. 158, 1-24.
16. MILLER, J.L., DONAHUE, R.E., SELLERS, S.E., SAMULSKI, R.J., YOUNG, N.S., and NIENHUIS, A.W. (1994). Recombinant adeno-associated virus (rAAV)-mediated expression of a human g-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91, 10183-10187.
17. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
18. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.
19. PODSAKOFF, G., WONG, K.K., JR., and CHATTERJEE, S. (1994). Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68, 5656-5666.
20. RUSSELL, D.W., MILLER, A.D., and ALEXANDER, I.E. (1994). Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91, 8915-8919.
21. SAMBROOK, J. (1989). Expression of cloned genes in cultured mammalian cells, In Molecular Cloning: A Laboratory Manual. J. Sambrook, E. Fritsch, and T. Maniatis, eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 16.66-16.67.
22. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUTNER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. (Published erratum appears in EMBO J. 11, 1228 1992.) EMBO J. 10, 3941-3950.
23. SAMULSKI, R.J., CHANG, L.-S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
24. SHELLING, A.N., and SMITH, M.G. (1994). Targeted integration of transfected and infected adeno-associated virus vectors containing the neiomycin resistance gene. Gene Ther. 1, 165-169.
25. WALSH, C.E., LIU, J.M., XIAO, X., YOUNG, N.S., NIENHUIS, A.W., and SAMULSKI, R.J. (1992). Regulated high level expression of a human g-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 89, 7257-7261.
26. WEITZMAN, M.D., KYÖSTIÖ, S.R.M., KOTIN, R.M., and OWENS, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 91, 5808-5812.
27. YANG, Y., TRINCHIERI, G., and WILSON, J.M. (1995). Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1, 890-893.
28. YANG, Y., ERTL, H.C.J., and WILSON, J.M. (1994). MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.
29. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.